ABT-202
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C9H13N3 |
| Molar mass | 163.224 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.